Cargando…

Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review

Tumor necrosis factor (TNF) is a pleiotropic cytokine involved in many aspects of immune regulation. Anti-TNF biological therapy has been considered a breakthrough in the treatment of chronic autoimmune diseases, such as rheumatoid arthritis (RA). In this review, because of the major involvement of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davignon, Jean-Luc, Rauwel, Benjamin, Degboé, Yannick, Constantin, Arnaud, Boyer, Jean-Fredéric, Kruglov, Andrey, Cantagrel, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235207/ https://www.ncbi.nlm.nih.gov/pubmed/30314507 http://dx.doi.org/10.1186/s13075-018-1725-6

Ejemplares similares

Maintenance of cytomegalovirus-specific CD4(pos )T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments
por: Davignon, Jean-Luc, et al.
Publicado: (2010)

Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling
por: Boyer, Jean Frédéric, et al.
Publicado: (2016)

Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
por: Degboé, Yannick, et al.
Publicado: (2019)

Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation
por: Diallo, Katy, et al.
Publicado: (2021)

Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
por: Sayegh, Souraya, et al.
Publicado: (2019)

Corrigendum: Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
por: Sayegh, Souraya, et al.
Publicado: (2019)

Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
por: Rauwel, B., et al.
Publicado: (2020)

No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysis
por: Baradat, Claire, et al.
Publicado: (2017)

Cytomegalovirus infection: friend or foe in rheumatoid arthritis?
por: Davignon, Jean-Luc, et al.
Publicado: (2021)

Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes
por: Boyer, Jean Frédéric, et al.
Publicado: (2007)

Short-term risk of major adverse cardiovascular events or congestive heart failure in patients with psoriatic arthritis or psoriasis initiating a biological therapy: a meta–analysis of randomised controlled trials
por: Champs, Bénédicte, et al.
Publicado: (2019)

Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort
por: Degboé, Yannick, et al.
Publicado: (2015)

Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent
por: Degboé, Yannick, et al.
Publicado: (2014)

A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis
por: Gourraud, Pierre-Antoine, et al.
Publicado: (2007)

Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
por: Degboé, Yannick, et al.
Publicado: (2020)

Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity
por: Ruyssen-Witrand, Adeline, et al.
Publicado: (2023)

Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort
por: Ruyssen-Witrand, Adeline, et al.
Publicado: (2017)

Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data
por: Ruyssen-Witrand, Adeline, et al.
Publicado: (2019)

New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples
por: Barnetche, Thomas, et al.
Publicado: (2008)

Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts
por: Ruyssen-Witrand, Adeline, et al.
Publicado: (2016)

Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy
por: Leboime, Ariane, et al.
Publicado: (2009)

Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study
por: Degboé, Yannick, et al.
Publicado: (2022)

Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study
por: Courvoisier, Natacha, et al.
Publicado: (2008)

Characteristics of the (Auto)Reactive T Cells in Rheumatoid Arthritis According to the Immune Epitope Database
por: Carlé, Caroline, et al.
Publicado: (2023)

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for early rheumatoid arthritis diagnosis
por: Nogueira, L, et al.
Publicado: (2003)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

Metabolic Profiling Predicts Response to Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis
por: Kapoor, Sabrina R, et al.
Publicado: (2013)

Epistatic Interaction between BANK1 and BLK in Rheumatoid Arthritis: Results from a Large Trans-Ethnic Meta-Analysis
por: Génin, Emmanuelle, et al.
Publicado: (2013)

Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2005)

Effect of risedronate on bone loss at discontinuation of denosumab
por: Laroche, Michel, et al.
Publicado: (2020)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
por: Emery, P, et al.
Publicado: (2008)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis
por: Meyer, Olivier, et al.
Publicado: (2006)

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
por: Julià, Antonio, et al.
Publicado: (2021)

Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
por: Cavazzana, I, et al.
Publicado: (2005)

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
por: Lukas, Cédric, et al.
Publicado: (2019)

Effect of periodontal treatment on the clinical parameters of patients with rheumatoid arthritis: study protocol of the randomized, controlled ESPERA trial
por: Monsarrat, Paul, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_89298mih8ammdgo04b2kvv899n